AlphaYouFL
Schedule 13G filing
Frazier Life Sciences Public Fund, L.P. disclosed a 5.4% stake in Aclaris Therapeutics, Inc. (ACRS)
Frazier Life Sciences Public Fund, L.P. reported owning 5.4% of Aclaris Therapeutics, Inc. (ACRS) (7,879,943 shares) in a Schedule 13G filed Sep 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 21, 2026
- Source
- Schedule 13G
More ACRS insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.